151 filings
ARS
2023 FY
TRVI
Trevi Therapeutics Inc
26 Apr 24
Annual report to shareholders
5:59pm
DEFA14A
TRVI
Trevi Therapeutics Inc
26 Apr 24
Additional proxy soliciting materials
4:44pm
DEF 14A
TRVI
Trevi Therapeutics Inc
Definitive proxy
26 Apr 24
4:38pm
S-8
TRVI
Trevi Therapeutics Inc
20 Mar 24
Registration of securities for employees
4:12pm
10-K
2023 FY
TRVI
Trevi Therapeutics Inc
Annual report
20 Mar 24
4:10pm
8-K
otnfo0ff n2
20 Mar 24
Trevi Therapeutics Reports Fourth Quarter and Year End 2023 Financial Results and Provides Business Updates
4:08pm
8-K
vopju61p76zd8v
9 Nov 23
Trevi Therapeutics Announces Third Quarter 2023 Financial Results and Provides Business Update
4:08pm
EFFECT
m4fb5zaylc17eyv
16 Aug 23
Notice of effectiveness
12:15am
CORRESP
0xdd3m7 z22018qh59as
14 Aug 23
Correspondence with SEC
12:00am
8-K
30v qgs3wquzk8gcjq
10 Aug 23
Trevi Therapeutics Announces Second Quarter 2023 Financial Results and Provides Business Update
4:08pm
UPLOAD
n6gxp4ng4
5 Jul 23
Letter from SEC
12:00am
8-K
npjoo
29 Jun 23
Amendments to Articles of Incorporation or Bylaws
4:02pm
S-8
4q13c67fvr lcl
11 May 23
Registration of securities for employees
4:16pm
8-K
w8cv6bmid9jt 07o
11 May 23
Trevi Therapeutics Announces First Quarter 2023 Financial Results and Provides Business Update
4:09pm
ARS
54h2y rev18zewhxz904
1 May 23
Annual report to shareholders
4:03pm